Simcere Pharmaceutical Group Ltd - ESG Rating & Company Profile powered by AI
This analysis of Simcere Pharmaceutical Group Ltd is assembled by All Street Sevva using leading Cognitive Robots. Scroll down to the bottom of the webpage for potential risks for Simcere Pharmaceutical Group Ltd based on sector, location and marketcap. The analysis of Simcere Pharmaceutical Group Ltd employs data points from across the web as well as from available documents by Simcere Pharmaceutical Group Ltd.
Simcere Pharmaceutical Group Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Simcere Pharmaceutical Group Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Simcere Pharmaceutical Group Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Simcere Pharmaceutical Group Ltd disclose current and historical energy intensity?
Does Simcere Pharmaceutical Group Ltd report the average age of the workforce?
Does Simcere Pharmaceutical Group Ltd reference operational or capital allocation in relation to climate change?
Does Simcere Pharmaceutical Group Ltd disclose its ethnicity pay gap?
Does Simcere Pharmaceutical Group Ltd disclose cybersecurity risks?
Does Simcere Pharmaceutical Group Ltd offer flexible work?
Does Simcere Pharmaceutical Group Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Simcere Pharmaceutical Group Ltd disclose the number of employees in R&D functions?
Does Simcere Pharmaceutical Group Ltd conduct supply chain audits?
Does Simcere Pharmaceutical Group Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Simcere Pharmaceutical Group Ltd conduct 360 degree staff reviews?
Does Simcere Pharmaceutical Group Ltd disclose the individual responsible for D&I?
Does Simcere Pharmaceutical Group Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Simcere Pharmaceutical Group Ltd disclose current and / or historical scope 2 emissions?
Does Simcere Pharmaceutical Group Ltd disclose water use targets?
Does Simcere Pharmaceutical Group Ltd have careers partnerships with academic institutions?
Did Simcere Pharmaceutical Group Ltd have a product recall in the last two years?
Does Simcere Pharmaceutical Group Ltd disclose incidents of discrimination?
Does Simcere Pharmaceutical Group Ltd allow for Work Councils/Collective Agreements to be formed?
Has Simcere Pharmaceutical Group Ltd issued a profit warning in the past 24 months?
Does Simcere Pharmaceutical Group Ltd disclose parental leave metrics?
Does Simcere Pharmaceutical Group Ltd disclose climate scenario or pathway analysis?
Does Simcere Pharmaceutical Group Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Simcere Pharmaceutical Group Ltd disclose the pay ratio of women to men?
Does Simcere Pharmaceutical Group Ltd support suppliers with sustainability related research and development?
Does Simcere Pharmaceutical Group Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Simcere Pharmaceutical Group Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Simcere Pharmaceutical Group Ltd involved in embryonic stem cell research?
Does Simcere Pharmaceutical Group Ltd disclose GHG and Air Emissions intensity?
Does Simcere Pharmaceutical Group Ltd disclose its waste policy?
Does Simcere Pharmaceutical Group Ltd report according to TCFD requirements?
Does Simcere Pharmaceutical Group Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Simcere Pharmaceutical Group Ltd disclose energy use targets?
Does Simcere Pharmaceutical Group Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Simcere Pharmaceutical Group Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Simcere Pharmaceutical Group Ltd
These potential risks are based on the size, segment and geographies of the company.
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and distribution of pharmaceutical and vaccine products for pharmaceutical distributors and government in China. Its principal branded generic pharmaceuticals include Bicun, a prescription edaravone injection pharmaceutical for the treatment of strokes; Zailin, a line of generic prescription amoxicillin antibiotics; Yingtaiqing, an anti-inflammatory pain reliever and analgesic drug used to treat rheumatoid arthritis and osteoarthritis; Enlength, an oncology injection; and Sinofuan for the treatment of cancer. The company also offers generic anti-diarrhea pharmaceutical products under the Biqi brand; amoxicillin and clavulanate potassium tablets, granules, and injection for the treatment of infections under the Anqi brand name; cefaclor in dry suspension antibiotics for the treatment of infections under the Zaike brand; herbal medicines for the treatment of coughs under the Kechuanning name; Jiebaishu, which is primarily used for the treatment of head and neck cancers, small cell lung carcinoma, non-small-cell lung carcinoma, esophageal cancer, and other solid tumors; and biapenem for the treatment of severe infections under the Anxin brand. In addition, it offers cardiovascular products; autoimmune products; anti-infective drugs; and other pharmaceutical products, such as Biqi-branded diosmectite powder and anti-diarrhea products. The company has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Simcere Pharmaceutical Group Limited was founded in 1995 and is headquartered in Nanjing, China.